UroGen Pharma URGN Q2 2025 earnings
Reported August 7, 2025 · Before market open
Revenue$24.2MMiss by $9.4M
EPS-$1.05Miss by $0.23
Revenue estimate$33.6M
EPS estimate-$0.82
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$63.5M
EPS estimate-$0.27
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment UroGen Pharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did UroGen Pharma report Q2 2025 earnings?
- UroGen Pharma (URGN) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were UroGen Pharma's Q2 2025 revenue and EPS?
- UroGen Pharma reported revenue of $24.2M and eps of $-1.05 for Q2 2025.
- Did UroGen Pharma beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $33.6M by $9.4M. EPS missed the consensus estimate of $-0.82 by $0.23.
- How did UroGen Pharma's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 10.8% from $21.8M a year earlier and eps declined 15.4% from $-0.91.
- Where can I find UroGen Pharma's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001437749-25-025243) directly on SEC EDGAR. The filing index links above go to sec.gov.